OBJECTIVES The purpose of this study was to explore the diagnostic usefulness of hybrid cardiac magnetic resonance (CMR) and positron emission tomography (PET) using F-18-fluorodeoxyglucose (FDG) for active cardiac sarcoidosis. BACKGROUND Active cardiac sarcoidosis (aCS) is underdiagnosed and has a high mortality. METHODS Patients with clinical suspicion of aCS underwent hybrid CMR/PET with late gadolinium enhancement (LGE) and FDG to assess the pattern of injury and disease activity, respectively. Patients were categorized visually as magnetic resonance (MR) thornPETthorn (characteristic LGE aligning exactly with increased FDG uptake), MR+PET - (characteristic LGE but no increased FDG), MR - PET - (neither characteristic LGE nor increased FDG), and MR - PET + (increased FDG uptake in absence of characteristic LGE) and further characterized as aCS + (MR+PET+) or aCS - (MR+PET -, MR - PET -, MR - PET+). FDG uptake was quantified using maximum target-to-normal-myocardium ratio and the net uptake rate (K-i) from dynamic Patlak analysis. Receiver-operating characteristic methods were used to identify imaging biomarkers for aCS. FDG PET was assessed using computed tomography/PET in 19 control subjects with healthy myocardium. RESULTS A total of 25 patients (12 males; 54.9 +/- 9.8 years of age) were recruited prospectively; 8 were MR+PET+, suggestive of aCS; 1 was MR+PET +, consistent with inactive cardiac sarcoidosis; and 8 were MR - PET -, with no imaging evidence of cardiac sarcoidosis. Eight patients were MR - PET+ (6 with global myocardial FDG uptake, 2 with focal-on-diffuse uptake); they demonstrated distinct Ki values and hyperintense maximum standardized uptake value compared with MR+PET+ patients. Similar hyperintense patterns of global (n = 9) and focal-on-diffuse (n = 2) FDG uptake were also observed in control patients, suggesting physiological myocardial uptake. Maximum target-to-normal-myocardium ratio values were higher in the aCS + group (p < 0.001), demonstrating an area under the curve of 0.98 on receiver-operating characteristic analysis for the detection of aCS, with an optimal maximum target-to-normal myocardium ratio threshold of 1.2 (Youden index: 0.94). CONCLUSIONS CMR/PET imaging holds major promise for the diagnosis of aCS, providing incremental information about both the pattern of injury and disease activity in a single scan. (c) 2018 by the American College of Cardiology Foundation.

Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis

Palmisano A;
2018-01-01

Abstract

OBJECTIVES The purpose of this study was to explore the diagnostic usefulness of hybrid cardiac magnetic resonance (CMR) and positron emission tomography (PET) using F-18-fluorodeoxyglucose (FDG) for active cardiac sarcoidosis. BACKGROUND Active cardiac sarcoidosis (aCS) is underdiagnosed and has a high mortality. METHODS Patients with clinical suspicion of aCS underwent hybrid CMR/PET with late gadolinium enhancement (LGE) and FDG to assess the pattern of injury and disease activity, respectively. Patients were categorized visually as magnetic resonance (MR) thornPETthorn (characteristic LGE aligning exactly with increased FDG uptake), MR+PET - (characteristic LGE but no increased FDG), MR - PET - (neither characteristic LGE nor increased FDG), and MR - PET + (increased FDG uptake in absence of characteristic LGE) and further characterized as aCS + (MR+PET+) or aCS - (MR+PET -, MR - PET -, MR - PET+). FDG uptake was quantified using maximum target-to-normal-myocardium ratio and the net uptake rate (K-i) from dynamic Patlak analysis. Receiver-operating characteristic methods were used to identify imaging biomarkers for aCS. FDG PET was assessed using computed tomography/PET in 19 control subjects with healthy myocardium. RESULTS A total of 25 patients (12 males; 54.9 +/- 9.8 years of age) were recruited prospectively; 8 were MR+PET+, suggestive of aCS; 1 was MR+PET +, consistent with inactive cardiac sarcoidosis; and 8 were MR - PET -, with no imaging evidence of cardiac sarcoidosis. Eight patients were MR - PET+ (6 with global myocardial FDG uptake, 2 with focal-on-diffuse uptake); they demonstrated distinct Ki values and hyperintense maximum standardized uptake value compared with MR+PET+ patients. Similar hyperintense patterns of global (n = 9) and focal-on-diffuse (n = 2) FDG uptake were also observed in control patients, suggesting physiological myocardial uptake. Maximum target-to-normal-myocardium ratio values were higher in the aCS + group (p < 0.001), demonstrating an area under the curve of 0.98 on receiver-operating characteristic analysis for the detection of aCS, with an optimal maximum target-to-normal myocardium ratio threshold of 1.2 (Youden index: 0.94). CONCLUSIONS CMR/PET imaging holds major promise for the diagnosis of aCS, providing incremental information about both the pattern of injury and disease activity in a single scan. (c) 2018 by the American College of Cardiology Foundation.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/135676
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 113
  • ???jsp.display-item.citation.isi??? 70
social impact